nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonorgestrel—PGR—blood vessel—stomach cancer	0.00926	0.0706	CbGeAlD
Levonorgestrel—SRD5A1—endocrine gland—stomach cancer	0.00864	0.0658	CbGeAlD
Levonorgestrel—SRD5A1—liver—stomach cancer	0.00779	0.0593	CbGeAlD
Levonorgestrel—ESR1—blood vessel—stomach cancer	0.00724	0.0552	CbGeAlD
Levonorgestrel—SHBG—hematopoietic system—stomach cancer	0.00548	0.0417	CbGeAlD
Levonorgestrel—PGR—hematopoietic system—stomach cancer	0.00493	0.0376	CbGeAlD
Levonorgestrel—PGR—epithelium—stomach cancer	0.00451	0.0343	CbGeAlD
Levonorgestrel—CYP19A1—hematopoietic system—stomach cancer	0.00444	0.0338	CbGeAlD
Levonorgestrel—PGR—smooth muscle tissue—stomach cancer	0.00434	0.0331	CbGeAlD
Levonorgestrel—AR—hematopoietic system—stomach cancer	0.00393	0.0299	CbGeAlD
Levonorgestrel—ESR1—hematopoietic system—stomach cancer	0.00386	0.0294	CbGeAlD
Levonorgestrel—AR—epithelium—stomach cancer	0.00359	0.0274	CbGeAlD
Levonorgestrel—ESR1—epithelium—stomach cancer	0.00353	0.0269	CbGeAlD
Levonorgestrel—SHBG—bone marrow—stomach cancer	0.00351	0.0267	CbGeAlD
Levonorgestrel—PGR—lymphoid tissue—stomach cancer	0.00347	0.0265	CbGeAlD
Levonorgestrel—AR—smooth muscle tissue—stomach cancer	0.00346	0.0264	CbGeAlD
Levonorgestrel—ESR1—smooth muscle tissue—stomach cancer	0.0034	0.0259	CbGeAlD
Levonorgestrel—SHBG—endocrine gland—stomach cancer	0.00315	0.024	CbGeAlD
Levonorgestrel—SHBG—liver—stomach cancer	0.00284	0.0216	CbGeAlD
Levonorgestrel—PGR—endocrine gland—stomach cancer	0.00283	0.0216	CbGeAlD
Levonorgestrel—AR—lymphoid tissue—stomach cancer	0.00277	0.0211	CbGeAlD
Levonorgestrel—AR—digestive system—stomach cancer	0.00273	0.0208	CbGeAlD
Levonorgestrel—ESR1—lymphoid tissue—stomach cancer	0.00272	0.0207	CbGeAlD
Levonorgestrel—ESR1—digestive system—stomach cancer	0.00268	0.0204	CbGeAlD
Levonorgestrel—CYP19A1—endocrine gland—stomach cancer	0.00255	0.0194	CbGeAlD
Levonorgestrel—CYP19A1—liver—stomach cancer	0.0023	0.0175	CbGeAlD
Levonorgestrel—AR—endocrine gland—stomach cancer	0.00226	0.0172	CbGeAlD
Levonorgestrel—ESR1—endocrine gland—stomach cancer	0.00222	0.0169	CbGeAlD
Levonorgestrel—CYP3A4—hematopoietic system—stomach cancer	0.00215	0.0164	CbGeAlD
Levonorgestrel—AR—liver—stomach cancer	0.00204	0.0155	CbGeAlD
Levonorgestrel—ESR1—liver—stomach cancer	0.002	0.0152	CbGeAlD
Levonorgestrel—PGR—lymph node—stomach cancer	0.00196	0.0149	CbGeAlD
Levonorgestrel—Hydrocortisone—ANXA1—stomach cancer	0.00184	0.599	CrCbGaD
Levonorgestrel—CYP19A1—lymph node—stomach cancer	0.00176	0.0134	CbGeAlD
Levonorgestrel—AR—lymph node—stomach cancer	0.00156	0.0119	CbGeAlD
Levonorgestrel—ESR1—lymph node—stomach cancer	0.00153	0.0117	CbGeAlD
Levonorgestrel—CYP3A4—digestive system—stomach cancer	0.0015	0.0114	CbGeAlD
Levonorgestrel—CYP3A4—endocrine gland—stomach cancer	0.00124	0.00942	CbGeAlD
Levonorgestrel—CYP3A4—liver—stomach cancer	0.00112	0.0085	CbGeAlD
Levonorgestrel—Progesterone—CYP2A6—stomach cancer	0.00046	0.15	CrCbGaD
Levonorgestrel—Visual impairment—Methotrexate—stomach cancer	0.00045	0.00089	CcSEcCtD
Levonorgestrel—Skin disorder—Docetaxel—stomach cancer	0.000448	0.000884	CcSEcCtD
Levonorgestrel—Oedema—Capecitabine—stomach cancer	0.000446	0.000881	CcSEcCtD
Levonorgestrel—Infection—Capecitabine—stomach cancer	0.000443	0.000875	CcSEcCtD
Levonorgestrel—Erythema multiforme—Methotrexate—stomach cancer	0.000442	0.000873	CcSEcCtD
Levonorgestrel—Dizziness—Irinotecan—stomach cancer	0.000441	0.000871	CcSEcCtD
Levonorgestrel—Haemoglobin—Epirubicin—stomach cancer	0.00044	0.000868	CcSEcCtD
Levonorgestrel—Anorexia—Docetaxel—stomach cancer	0.000439	0.000867	CcSEcCtD
Levonorgestrel—Shock—Capecitabine—stomach cancer	0.000439	0.000867	CcSEcCtD
Levonorgestrel—Rhinitis—Epirubicin—stomach cancer	0.000439	0.000866	CcSEcCtD
Levonorgestrel—Urinary tract infection—Doxorubicin—stomach cancer	0.000438	0.000866	CcSEcCtD
Levonorgestrel—Nervous system disorder—Capecitabine—stomach cancer	0.000437	0.000864	CcSEcCtD
Levonorgestrel—Haemorrhage—Epirubicin—stomach cancer	0.000437	0.000864	CcSEcCtD
Levonorgestrel—Eye disorder—Methotrexate—stomach cancer	0.000437	0.000863	CcSEcCtD
Levonorgestrel—Diarrhoea—Fluorouracil—stomach cancer	0.000437	0.000863	CcSEcCtD
Levonorgestrel—Hypoaesthesia—Epirubicin—stomach cancer	0.000435	0.00086	CcSEcCtD
Levonorgestrel—Pharyngitis—Epirubicin—stomach cancer	0.000434	0.000857	CcSEcCtD
Levonorgestrel—Cardiac disorder—Methotrexate—stomach cancer	0.000434	0.000857	CcSEcCtD
Levonorgestrel—Skin disorder—Capecitabine—stomach cancer	0.000433	0.000856	CcSEcCtD
Levonorgestrel—Urinary tract disorder—Epirubicin—stomach cancer	0.000432	0.000853	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Capecitabine—stomach cancer	0.000431	0.000852	CcSEcCtD
Levonorgestrel—Connective tissue disorder—Epirubicin—stomach cancer	0.00043	0.000849	CcSEcCtD
Levonorgestrel—Urethral disorder—Epirubicin—stomach cancer	0.000429	0.000847	CcSEcCtD
Levonorgestrel—Anorexia—Capecitabine—stomach cancer	0.000425	0.00084	CcSEcCtD
Levonorgestrel—Vomiting—Irinotecan—stomach cancer	0.000424	0.000837	CcSEcCtD
Levonorgestrel—Sinusitis—Doxorubicin—stomach cancer	0.000423	0.000835	CcSEcCtD
Levonorgestrel—Immune system disorder—Methotrexate—stomach cancer	0.000422	0.000834	CcSEcCtD
Levonorgestrel—Dizziness—Fluorouracil—stomach cancer	0.000422	0.000834	CcSEcCtD
Levonorgestrel—Visual impairment—Epirubicin—stomach cancer	0.000422	0.000833	CcSEcCtD
Levonorgestrel—Mediastinal disorder—Methotrexate—stomach cancer	0.000421	0.000832	CcSEcCtD
Levonorgestrel—Rash—Irinotecan—stomach cancer	0.00042	0.00083	CcSEcCtD
Levonorgestrel—Dermatitis—Irinotecan—stomach cancer	0.00042	0.000829	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.00042	0.000829	CcSEcCtD
Levonorgestrel—Headache—Irinotecan—stomach cancer	0.000418	0.000825	CcSEcCtD
Levonorgestrel—Insomnia—Docetaxel—stomach cancer	0.000417	0.000823	CcSEcCtD
Levonorgestrel—Erythema multiforme—Epirubicin—stomach cancer	0.000414	0.000817	CcSEcCtD
Levonorgestrel—Alopecia—Methotrexate—stomach cancer	0.000413	0.000816	CcSEcCtD
Levonorgestrel—Dyspnoea—Docetaxel—stomach cancer	0.000411	0.000811	CcSEcCtD
Levonorgestrel—Somnolence—Docetaxel—stomach cancer	0.00041	0.000809	CcSEcCtD
Levonorgestrel—Mental disorder—Methotrexate—stomach cancer	0.000409	0.000809	CcSEcCtD
Levonorgestrel—Eye disorder—Epirubicin—stomach cancer	0.000409	0.000807	CcSEcCtD
Levonorgestrel—Erythema—Methotrexate—stomach cancer	0.000407	0.000804	CcSEcCtD
Levonorgestrel—Malnutrition—Methotrexate—stomach cancer	0.000407	0.000804	CcSEcCtD
Levonorgestrel—Haemoglobin—Doxorubicin—stomach cancer	0.000407	0.000803	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000406	0.000803	CcSEcCtD
Levonorgestrel—Cardiac disorder—Epirubicin—stomach cancer	0.000406	0.000802	CcSEcCtD
Levonorgestrel—Vomiting—Fluorouracil—stomach cancer	0.000406	0.000802	CcSEcCtD
Levonorgestrel—Rhinitis—Doxorubicin—stomach cancer	0.000406	0.000801	CcSEcCtD
Levonorgestrel—Dyspepsia—Docetaxel—stomach cancer	0.000406	0.000801	CcSEcCtD
Levonorgestrel—Haemorrhage—Doxorubicin—stomach cancer	0.000405	0.000799	CcSEcCtD
Levonorgestrel—Insomnia—Capecitabine—stomach cancer	0.000403	0.000797	CcSEcCtD
Levonorgestrel—Hypoaesthesia—Doxorubicin—stomach cancer	0.000403	0.000795	CcSEcCtD
Levonorgestrel—Rash—Fluorouracil—stomach cancer	0.000402	0.000795	CcSEcCtD
Levonorgestrel—Dermatitis—Fluorouracil—stomach cancer	0.000402	0.000794	CcSEcCtD
Levonorgestrel—Pharyngitis—Doxorubicin—stomach cancer	0.000402	0.000793	CcSEcCtD
Levonorgestrel—Decreased appetite—Docetaxel—stomach cancer	0.0004	0.000791	CcSEcCtD
Levonorgestrel—Headache—Fluorouracil—stomach cancer	0.0004	0.00079	CcSEcCtD
Levonorgestrel—Urinary tract disorder—Doxorubicin—stomach cancer	0.0004	0.000789	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000398	0.000786	CcSEcCtD
Levonorgestrel—Connective tissue disorder—Doxorubicin—stomach cancer	0.000398	0.000786	CcSEcCtD
Levonorgestrel—Dyspnoea—Capecitabine—stomach cancer	0.000398	0.000786	CcSEcCtD
Levonorgestrel—Fatigue—Docetaxel—stomach cancer	0.000397	0.000785	CcSEcCtD
Levonorgestrel—Urethral disorder—Doxorubicin—stomach cancer	0.000397	0.000784	CcSEcCtD
Levonorgestrel—Nausea—Irinotecan—stomach cancer	0.000396	0.000782	CcSEcCtD
Levonorgestrel—Immune system disorder—Epirubicin—stomach cancer	0.000395	0.00078	CcSEcCtD
Levonorgestrel—Mediastinal disorder—Epirubicin—stomach cancer	0.000394	0.000779	CcSEcCtD
Levonorgestrel—Constipation—Docetaxel—stomach cancer	0.000394	0.000778	CcSEcCtD
Levonorgestrel—Pain—Docetaxel—stomach cancer	0.000394	0.000778	CcSEcCtD
Levonorgestrel—Back pain—Methotrexate—stomach cancer	0.000394	0.000777	CcSEcCtD
Levonorgestrel—Dyspepsia—Capecitabine—stomach cancer	0.000393	0.000776	CcSEcCtD
Levonorgestrel—Arrhythmia—Epirubicin—stomach cancer	0.000391	0.000772	CcSEcCtD
Levonorgestrel—Visual impairment—Doxorubicin—stomach cancer	0.00039	0.00077	CcSEcCtD
Levonorgestrel—Decreased appetite—Capecitabine—stomach cancer	0.000388	0.000766	CcSEcCtD
Levonorgestrel—Alopecia—Epirubicin—stomach cancer	0.000387	0.000763	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000385	0.000761	CcSEcCtD
Levonorgestrel—Fatigue—Capecitabine—stomach cancer	0.000385	0.00076	CcSEcCtD
Levonorgestrel—Mental disorder—Epirubicin—stomach cancer	0.000383	0.000757	CcSEcCtD
Levonorgestrel—Erythema multiforme—Doxorubicin—stomach cancer	0.000383	0.000756	CcSEcCtD
Levonorgestrel—Constipation—Capecitabine—stomach cancer	0.000381	0.000753	CcSEcCtD
Levonorgestrel—Pain—Capecitabine—stomach cancer	0.000381	0.000753	CcSEcCtD
Levonorgestrel—Malnutrition—Epirubicin—stomach cancer	0.000381	0.000752	CcSEcCtD
Levonorgestrel—Erythema—Epirubicin—stomach cancer	0.000381	0.000752	CcSEcCtD
Levonorgestrel—Nausea—Fluorouracil—stomach cancer	0.000379	0.000749	CcSEcCtD
Levonorgestrel—Eye disorder—Doxorubicin—stomach cancer	0.000378	0.000747	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Docetaxel—stomach cancer	0.000377	0.000744	CcSEcCtD
Levonorgestrel—Anaemia—Methotrexate—stomach cancer	0.000376	0.000743	CcSEcCtD
Levonorgestrel—Cardiac disorder—Doxorubicin—stomach cancer	0.000376	0.000742	CcSEcCtD
Levonorgestrel—Flatulence—Epirubicin—stomach cancer	0.000375	0.000741	CcSEcCtD
Levonorgestrel—Tension—Epirubicin—stomach cancer	0.000374	0.000738	CcSEcCtD
Levonorgestrel—Nervousness—Epirubicin—stomach cancer	0.00037	0.00073	CcSEcCtD
Levonorgestrel—Back pain—Epirubicin—stomach cancer	0.000368	0.000727	CcSEcCtD
Levonorgestrel—Muscle spasms—Epirubicin—stomach cancer	0.000366	0.000723	CcSEcCtD
Levonorgestrel—Immune system disorder—Doxorubicin—stomach cancer	0.000366	0.000722	CcSEcCtD
Levonorgestrel—Vertigo—Methotrexate—stomach cancer	0.000366	0.000722	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Capecitabine—stomach cancer	0.000365	0.00072	CcSEcCtD
Levonorgestrel—Mediastinal disorder—Doxorubicin—stomach cancer	0.000365	0.00072	CcSEcCtD
Levonorgestrel—Abdominal pain—Docetaxel—stomach cancer	0.000364	0.000719	CcSEcCtD
Levonorgestrel—Body temperature increased—Docetaxel—stomach cancer	0.000364	0.000719	CcSEcCtD
Levonorgestrel—Arrhythmia—Doxorubicin—stomach cancer	0.000362	0.000714	CcSEcCtD
Levonorgestrel—Alopecia—Doxorubicin—stomach cancer	0.000358	0.000706	CcSEcCtD
Levonorgestrel—Cough—Methotrexate—stomach cancer	0.000355	0.000701	CcSEcCtD
Levonorgestrel—Mental disorder—Doxorubicin—stomach cancer	0.000355	0.0007	CcSEcCtD
Levonorgestrel—Urticaria—Capecitabine—stomach cancer	0.000354	0.0007	CcSEcCtD
Levonorgestrel—Abdominal pain—Capecitabine—stomach cancer	0.000353	0.000697	CcSEcCtD
Levonorgestrel—Body temperature increased—Capecitabine—stomach cancer	0.000353	0.000697	CcSEcCtD
Levonorgestrel—Erythema—Doxorubicin—stomach cancer	0.000352	0.000696	CcSEcCtD
Levonorgestrel—Malnutrition—Doxorubicin—stomach cancer	0.000352	0.000696	CcSEcCtD
Levonorgestrel—Anaemia—Epirubicin—stomach cancer	0.000352	0.000695	CcSEcCtD
Levonorgestrel—Flatulence—Doxorubicin—stomach cancer	0.000347	0.000686	CcSEcCtD
Levonorgestrel—Myalgia—Methotrexate—stomach cancer	0.000346	0.000684	CcSEcCtD
Levonorgestrel—Chest pain—Methotrexate—stomach cancer	0.000346	0.000684	CcSEcCtD
Levonorgestrel—Tension—Doxorubicin—stomach cancer	0.000346	0.000683	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000344	0.000679	CcSEcCtD
Levonorgestrel—Discomfort—Methotrexate—stomach cancer	0.000342	0.000676	CcSEcCtD
Levonorgestrel—Nervousness—Doxorubicin—stomach cancer	0.000342	0.000676	CcSEcCtD
Levonorgestrel—Vertigo—Epirubicin—stomach cancer	0.000342	0.000676	CcSEcCtD
Levonorgestrel—Syncope—Epirubicin—stomach cancer	0.000341	0.000674	CcSEcCtD
Levonorgestrel—Back pain—Doxorubicin—stomach cancer	0.000341	0.000673	CcSEcCtD
Levonorgestrel—Hypersensitivity—Docetaxel—stomach cancer	0.000339	0.00067	CcSEcCtD
Levonorgestrel—Muscle spasms—Doxorubicin—stomach cancer	0.000339	0.000669	CcSEcCtD
Levonorgestrel—Palpitations—Epirubicin—stomach cancer	0.000336	0.000665	CcSEcCtD
Levonorgestrel—Loss of consciousness—Epirubicin—stomach cancer	0.000335	0.000661	CcSEcCtD
Levonorgestrel—Cough—Epirubicin—stomach cancer	0.000332	0.000656	CcSEcCtD
Levonorgestrel—Asthenia—Docetaxel—stomach cancer	0.000331	0.000653	CcSEcCtD
Levonorgestrel—Infection—Methotrexate—stomach cancer	0.00033	0.000652	CcSEcCtD
Levonorgestrel—Hypertension—Epirubicin—stomach cancer	0.000329	0.000649	CcSEcCtD
Levonorgestrel—Hypersensitivity—Capecitabine—stomach cancer	0.000329	0.000649	CcSEcCtD
Levonorgestrel—Pruritus—Docetaxel—stomach cancer	0.000326	0.000644	CcSEcCtD
Levonorgestrel—Nervous system disorder—Methotrexate—stomach cancer	0.000326	0.000643	CcSEcCtD
Levonorgestrel—Anaemia—Doxorubicin—stomach cancer	0.000326	0.000643	CcSEcCtD
Levonorgestrel—Chest pain—Epirubicin—stomach cancer	0.000324	0.00064	CcSEcCtD
Levonorgestrel—Myalgia—Epirubicin—stomach cancer	0.000324	0.00064	CcSEcCtD
Levonorgestrel—Anxiety—Epirubicin—stomach cancer	0.000323	0.000638	CcSEcCtD
Levonorgestrel—Skin disorder—Methotrexate—stomach cancer	0.000323	0.000637	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000322	0.000636	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Methotrexate—stomach cancer	0.000321	0.000634	CcSEcCtD
Levonorgestrel—Discomfort—Epirubicin—stomach cancer	0.00032	0.000633	CcSEcCtD
Levonorgestrel—Asthenia—Capecitabine—stomach cancer	0.00032	0.000632	CcSEcCtD
Levonorgestrel—Vertigo—Doxorubicin—stomach cancer	0.000317	0.000625	CcSEcCtD
Levonorgestrel—Anorexia—Methotrexate—stomach cancer	0.000317	0.000625	CcSEcCtD
Levonorgestrel—Syncope—Doxorubicin—stomach cancer	0.000316	0.000624	CcSEcCtD
Levonorgestrel—Pruritus—Capecitabine—stomach cancer	0.000316	0.000623	CcSEcCtD
Levonorgestrel—Diarrhoea—Docetaxel—stomach cancer	0.000315	0.000623	CcSEcCtD
Levonorgestrel—Palpitations—Doxorubicin—stomach cancer	0.000311	0.000615	CcSEcCtD
Levonorgestrel—Oedema—Epirubicin—stomach cancer	0.000311	0.000614	CcSEcCtD
Levonorgestrel—Loss of consciousness—Doxorubicin—stomach cancer	0.00031	0.000612	CcSEcCtD
Levonorgestrel—Infection—Epirubicin—stomach cancer	0.000309	0.00061	CcSEcCtD
Levonorgestrel—Norethindrone—ALB—stomach cancer	0.000308	0.1	CrCbGaD
Levonorgestrel—Cough—Doxorubicin—stomach cancer	0.000307	0.000607	CcSEcCtD
Levonorgestrel—Shock—Epirubicin—stomach cancer	0.000306	0.000604	CcSEcCtD
Levonorgestrel—Diarrhoea—Capecitabine—stomach cancer	0.000305	0.000603	CcSEcCtD
Levonorgestrel—Nervous system disorder—Epirubicin—stomach cancer	0.000305	0.000602	CcSEcCtD
Levonorgestrel—Dizziness—Docetaxel—stomach cancer	0.000305	0.000602	CcSEcCtD
Levonorgestrel—Hypertension—Doxorubicin—stomach cancer	0.000304	0.000601	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000303	0.000598	CcSEcCtD
Levonorgestrel—Skin disorder—Epirubicin—stomach cancer	0.000302	0.000596	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Epirubicin—stomach cancer	0.0003	0.000593	CcSEcCtD
Levonorgestrel—Insomnia—Methotrexate—stomach cancer	0.0003	0.000593	CcSEcCtD
Levonorgestrel—Chest pain—Doxorubicin—stomach cancer	0.0003	0.000592	CcSEcCtD
Levonorgestrel—Myalgia—Doxorubicin—stomach cancer	0.0003	0.000592	CcSEcCtD
Levonorgestrel—Anxiety—Doxorubicin—stomach cancer	0.000299	0.00059	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000298	0.000588	CcSEcCtD
Levonorgestrel—Discomfort—Doxorubicin—stomach cancer	0.000296	0.000585	CcSEcCtD
Levonorgestrel—Anorexia—Epirubicin—stomach cancer	0.000296	0.000585	CcSEcCtD
Levonorgestrel—Dyspnoea—Methotrexate—stomach cancer	0.000296	0.000585	CcSEcCtD
Levonorgestrel—Somnolence—Methotrexate—stomach cancer	0.000295	0.000583	CcSEcCtD
Levonorgestrel—Dizziness—Capecitabine—stomach cancer	0.000295	0.000583	CcSEcCtD
Levonorgestrel—Vomiting—Docetaxel—stomach cancer	0.000293	0.000579	CcSEcCtD
Levonorgestrel—Methyltestosterone—ALB—stomach cancer	0.000293	0.0953	CrCbGaD
Levonorgestrel—Dyspepsia—Methotrexate—stomach cancer	0.000292	0.000577	CcSEcCtD
Levonorgestrel—Rash—Docetaxel—stomach cancer	0.00029	0.000574	CcSEcCtD
Levonorgestrel—Dermatitis—Docetaxel—stomach cancer	0.00029	0.000573	CcSEcCtD
Levonorgestrel—Decreased appetite—Methotrexate—stomach cancer	0.000289	0.00057	CcSEcCtD
Levonorgestrel—Headache—Docetaxel—stomach cancer	0.000289	0.00057	CcSEcCtD
Levonorgestrel—Oedema—Doxorubicin—stomach cancer	0.000288	0.000568	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000287	0.000566	CcSEcCtD
Levonorgestrel—Fatigue—Methotrexate—stomach cancer	0.000286	0.000565	CcSEcCtD
Levonorgestrel—Infection—Doxorubicin—stomach cancer	0.000286	0.000564	CcSEcCtD
Levonorgestrel—Pain—Methotrexate—stomach cancer	0.000284	0.000561	CcSEcCtD
Levonorgestrel—Vomiting—Capecitabine—stomach cancer	0.000284	0.00056	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000283	0.000559	CcSEcCtD
Levonorgestrel—Shock—Doxorubicin—stomach cancer	0.000283	0.000559	CcSEcCtD
Levonorgestrel—Nervous system disorder—Doxorubicin—stomach cancer	0.000282	0.000557	CcSEcCtD
Levonorgestrel—Rash—Capecitabine—stomach cancer	0.000281	0.000556	CcSEcCtD
Levonorgestrel—Insomnia—Epirubicin—stomach cancer	0.000281	0.000555	CcSEcCtD
Levonorgestrel—Dermatitis—Capecitabine—stomach cancer	0.000281	0.000555	CcSEcCtD
Levonorgestrel—Headache—Capecitabine—stomach cancer	0.000279	0.000552	CcSEcCtD
Levonorgestrel—Skin disorder—Doxorubicin—stomach cancer	0.000279	0.000552	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Doxorubicin—stomach cancer	0.000278	0.000549	CcSEcCtD
Levonorgestrel—Dyspnoea—Epirubicin—stomach cancer	0.000277	0.000547	CcSEcCtD
Levonorgestrel—Somnolence—Epirubicin—stomach cancer	0.000276	0.000546	CcSEcCtD
Levonorgestrel—Anorexia—Doxorubicin—stomach cancer	0.000274	0.000541	CcSEcCtD
Levonorgestrel—Nausea—Docetaxel—stomach cancer	0.000274	0.000541	CcSEcCtD
Levonorgestrel—Dyspepsia—Epirubicin—stomach cancer	0.000274	0.00054	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Methotrexate—stomach cancer	0.000272	0.000536	CcSEcCtD
Levonorgestrel—Decreased appetite—Epirubicin—stomach cancer	0.00027	0.000534	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000268	0.00053	CcSEcCtD
Levonorgestrel—Fatigue—Epirubicin—stomach cancer	0.000268	0.000529	CcSEcCtD
Levonorgestrel—Pain—Epirubicin—stomach cancer	0.000266	0.000525	CcSEcCtD
Levonorgestrel—Constipation—Epirubicin—stomach cancer	0.000266	0.000525	CcSEcCtD
Levonorgestrel—Nausea—Capecitabine—stomach cancer	0.000265	0.000523	CcSEcCtD
Levonorgestrel—Urticaria—Methotrexate—stomach cancer	0.000264	0.000521	CcSEcCtD
Levonorgestrel—Abdominal pain—Methotrexate—stomach cancer	0.000262	0.000518	CcSEcCtD
Levonorgestrel—Body temperature increased—Methotrexate—stomach cancer	0.000262	0.000518	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000262	0.000517	CcSEcCtD
Levonorgestrel—Insomnia—Doxorubicin—stomach cancer	0.00026	0.000514	CcSEcCtD
Levonorgestrel—Dyspnoea—Doxorubicin—stomach cancer	0.000256	0.000506	CcSEcCtD
Levonorgestrel—Somnolence—Doxorubicin—stomach cancer	0.000256	0.000505	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Epirubicin—stomach cancer	0.000254	0.000502	CcSEcCtD
Levonorgestrel—Dyspepsia—Doxorubicin—stomach cancer	0.000253	0.0005	CcSEcCtD
Levonorgestrel—Decreased appetite—Doxorubicin—stomach cancer	0.00025	0.000494	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000248	0.00049	CcSEcCtD
Levonorgestrel—Fatigue—Doxorubicin—stomach cancer	0.000248	0.00049	CcSEcCtD
Levonorgestrel—Urticaria—Epirubicin—stomach cancer	0.000247	0.000488	CcSEcCtD
Levonorgestrel—Constipation—Doxorubicin—stomach cancer	0.000246	0.000486	CcSEcCtD
Levonorgestrel—Pain—Doxorubicin—stomach cancer	0.000246	0.000486	CcSEcCtD
Levonorgestrel—Body temperature increased—Epirubicin—stomach cancer	0.000246	0.000485	CcSEcCtD
Levonorgestrel—Abdominal pain—Epirubicin—stomach cancer	0.000246	0.000485	CcSEcCtD
Levonorgestrel—Hypersensitivity—Methotrexate—stomach cancer	0.000245	0.000483	CcSEcCtD
Levonorgestrel—Asthenia—Methotrexate—stomach cancer	0.000238	0.000471	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000235	0.000464	CcSEcCtD
Levonorgestrel—Pruritus—Methotrexate—stomach cancer	0.000235	0.000464	CcSEcCtD
Levonorgestrel—Hypersensitivity—Epirubicin—stomach cancer	0.000229	0.000452	CcSEcCtD
Levonorgestrel—Urticaria—Doxorubicin—stomach cancer	0.000228	0.000451	CcSEcCtD
Levonorgestrel—Abdominal pain—Doxorubicin—stomach cancer	0.000227	0.000449	CcSEcCtD
Levonorgestrel—Body temperature increased—Doxorubicin—stomach cancer	0.000227	0.000449	CcSEcCtD
Levonorgestrel—Diarrhoea—Methotrexate—stomach cancer	0.000227	0.000449	CcSEcCtD
Levonorgestrel—Asthenia—Epirubicin—stomach cancer	0.000223	0.00044	CcSEcCtD
Levonorgestrel—Pruritus—Epirubicin—stomach cancer	0.00022	0.000434	CcSEcCtD
Levonorgestrel—Dizziness—Methotrexate—stomach cancer	0.00022	0.000434	CcSEcCtD
Levonorgestrel—Diarrhoea—Epirubicin—stomach cancer	0.000213	0.00042	CcSEcCtD
Levonorgestrel—Hypersensitivity—Doxorubicin—stomach cancer	0.000212	0.000418	CcSEcCtD
Levonorgestrel—Vomiting—Methotrexate—stomach cancer	0.000211	0.000417	CcSEcCtD
Levonorgestrel—Rash—Methotrexate—stomach cancer	0.000209	0.000414	CcSEcCtD
Levonorgestrel—Dermatitis—Methotrexate—stomach cancer	0.000209	0.000413	CcSEcCtD
Levonorgestrel—Headache—Methotrexate—stomach cancer	0.000208	0.000411	CcSEcCtD
Levonorgestrel—Asthenia—Doxorubicin—stomach cancer	0.000206	0.000407	CcSEcCtD
Levonorgestrel—Dizziness—Epirubicin—stomach cancer	0.000205	0.000406	CcSEcCtD
Levonorgestrel—Pruritus—Doxorubicin—stomach cancer	0.000203	0.000402	CcSEcCtD
Levonorgestrel—Vomiting—Epirubicin—stomach cancer	0.000198	0.00039	CcSEcCtD
Levonorgestrel—Nausea—Methotrexate—stomach cancer	0.000197	0.00039	CcSEcCtD
Levonorgestrel—Diarrhoea—Doxorubicin—stomach cancer	0.000197	0.000389	CcSEcCtD
Levonorgestrel—Rash—Epirubicin—stomach cancer	0.000196	0.000387	CcSEcCtD
Levonorgestrel—Dermatitis—Epirubicin—stomach cancer	0.000196	0.000387	CcSEcCtD
Levonorgestrel—Headache—Epirubicin—stomach cancer	0.000195	0.000385	CcSEcCtD
Levonorgestrel—Dizziness—Doxorubicin—stomach cancer	0.00019	0.000376	CcSEcCtD
Levonorgestrel—Nausea—Epirubicin—stomach cancer	0.000185	0.000365	CcSEcCtD
Levonorgestrel—Vomiting—Doxorubicin—stomach cancer	0.000183	0.000361	CcSEcCtD
Levonorgestrel—Rash—Doxorubicin—stomach cancer	0.000181	0.000358	CcSEcCtD
Levonorgestrel—Dermatitis—Doxorubicin—stomach cancer	0.000181	0.000358	CcSEcCtD
Levonorgestrel—Headache—Doxorubicin—stomach cancer	0.00018	0.000356	CcSEcCtD
Levonorgestrel—Nausea—Doxorubicin—stomach cancer	0.000171	0.000337	CcSEcCtD
Levonorgestrel—Testosterone—ALB—stomach cancer	0.00017	0.0553	CrCbGaD
Levonorgestrel—AR—Gene Expression—HSPB1—stomach cancer	0.000117	0.000326	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	0.000117	0.000326	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—MAPK1—stomach cancer	0.000117	0.000325	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—EGFR—stomach cancer	0.000117	0.000325	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—RBP4—stomach cancer	0.000116	0.000324	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—IL6—stomach cancer	0.000114	0.000318	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—RPS19—stomach cancer	0.000114	0.000318	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—FADS1—stomach cancer	0.000113	0.000315	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—TYMP—stomach cancer	0.000113	0.000315	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—DNMT3B—stomach cancer	0.000113	0.000315	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—PPARG—stomach cancer	0.000113	0.000313	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—KRAS—stomach cancer	0.000111	0.000309	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—RPL15—stomach cancer	0.000111	0.000309	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—KRAS—stomach cancer	0.00011	0.000307	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—TP53—stomach cancer	0.00011	0.000307	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—PPP2R1A—stomach cancer	0.00011	0.000306	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	0.00011	0.000305	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—DNMT1—stomach cancer	0.000109	0.000304	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—WWOX—stomach cancer	0.000109	0.000303	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	0.000108	0.000301	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—RARB—stomach cancer	0.000108	0.0003	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—HSPA8—stomach cancer	0.000108	0.000299	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	0.000106	0.000295	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—SREBF2—stomach cancer	0.000106	0.000295	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—RORA—stomach cancer	0.000105	0.000292	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—RPS26—stomach cancer	0.000103	0.000288	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	0.000102	0.000285	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—SMAD4—stomach cancer	0.000102	0.000284	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—PIK3CA—stomach cancer	0.000101	0.000282	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—SERPINE1—stomach cancer	0.000101	0.000282	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HRH4—stomach cancer	0.000101	0.000282	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—WIF1—stomach cancer	0.000101	0.000282	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—RPS6—stomach cancer	0.000101	0.000281	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—HSPB1—stomach cancer	0.0001	0.000279	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—AGTR2—stomach cancer	0.0001	0.000279	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	9.95e-05	0.000277	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—BMP2—stomach cancer	9.9e-05	0.000275	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—F2R—stomach cancer	9.9e-05	0.000275	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—TP53—stomach cancer	9.86e-05	0.000274	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ALDOB—stomach cancer	9.82e-05	0.000273	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—AKR1C3—stomach cancer	9.74e-05	0.000271	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	9.73e-05	0.000271	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	9.73e-05	0.000271	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—HTR1A—stomach cancer	9.64e-05	0.000268	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—GSTP1—stomach cancer	9.39e-05	0.000261	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—HRAS—stomach cancer	9.38e-05	0.000261	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PRKAB1—stomach cancer	9.34e-05	0.00026	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—ERCC2—stomach cancer	9.33e-05	0.00026	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—ANXA1—stomach cancer	9.31e-05	0.000259	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	9.27e-05	0.000258	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metapathway biotransformation—GSTP1—stomach cancer	9.27e-05	0.000258	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	9.26e-05	0.000258	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	9.24e-05	0.000257	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	9.19e-05	0.000256	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ALOX5—stomach cancer	9.13e-05	0.000254	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—HSPB1—stomach cancer	9.04e-05	0.000252	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—KISS1—stomach cancer	9.02e-05	0.000251	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—RNF43—stomach cancer	9.02e-05	0.000251	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—ADRB1—stomach cancer	9.02e-05	0.000251	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—DPYD—stomach cancer	8.98e-05	0.00025	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—IL6—stomach cancer	8.98e-05	0.00025	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—RPS19—stomach cancer	8.79e-05	0.000245	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—PPARG—stomach cancer	8.67e-05	0.000241	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—GSTM1—stomach cancer	8.63e-05	0.00024	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—RPS6—stomach cancer	8.61e-05	0.00024	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	8.51e-05	0.000237	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	8.45e-05	0.000235	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—MYC—stomach cancer	8.42e-05	0.000234	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—DNMT1—stomach cancer	8.4e-05	0.000234	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—PPP2R1A—stomach cancer	8.39e-05	0.000233	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—HSPA8—stomach cancer	8.29e-05	0.000231	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	8.17e-05	0.000227	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	8.14e-05	0.000227	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—PIK3CA—stomach cancer	8.08e-05	0.000225	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ACAD8—stomach cancer	8.08e-05	0.000225	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—FST—stomach cancer	8.04e-05	0.000224	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GSTT1—stomach cancer	7.94e-05	0.000221	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—HBEGF—stomach cancer	7.92e-05	0.00022	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CYP2A6—stomach cancer	7.85e-05	0.000218	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—SERPINE1—stomach cancer	7.81e-05	0.000217	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—SMAD4—stomach cancer	7.79e-05	0.000217	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—RPS6—stomach cancer	7.78e-05	0.000216	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—RGS2—stomach cancer	7.75e-05	0.000216	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GAST—stomach cancer	7.75e-05	0.000216	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—AKR1C3—stomach cancer	7.64e-05	0.000212	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ENO1—stomach cancer	7.44e-05	0.000207	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—FGG—stomach cancer	7.35e-05	0.000205	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—ALB—stomach cancer	7.32e-05	0.000204	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—ADRB2—stomach cancer	7.3e-05	0.000203	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GMPR2—stomach cancer	7.2e-05	0.0002	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PPP2R1A—stomach cancer	7.16e-05	0.000199	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—PPARG—stomach cancer	7.11e-05	0.000198	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—ERCC2—stomach cancer	7.11e-05	0.000198	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PRKAA1—stomach cancer	7.08e-05	0.000197	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—RBP4—stomach cancer	6.83e-05	0.00019	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—SMAD4—stomach cancer	6.65e-05	0.000185	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CD44—stomach cancer	6.6e-05	0.000184	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—IDH3B—stomach cancer	6.58e-05	0.000183	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SUCLG1—stomach cancer	6.58e-05	0.000183	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—PPP2R1A—stomach cancer	6.46e-05	0.00018	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—MYC—stomach cancer	6.42e-05	0.000179	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—SERPINE1—stomach cancer	6.41e-05	0.000178	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	6.4e-05	0.000178	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—FYN—stomach cancer	6.31e-05	0.000176	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—NDUFV1—stomach cancer	6.12e-05	0.00017	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—NDUFS1—stomach cancer	6.12e-05	0.00017	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—SMAD4—stomach cancer	6e-05	0.000167	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—FGFR2—stomach cancer	5.92e-05	0.000165	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HSPB1—stomach cancer	5.88e-05	0.000164	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—AGTR2—stomach cancer	5.88e-05	0.000164	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—BMP2—stomach cancer	5.81e-05	0.000162	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—F2R—stomach cancer	5.81e-05	0.000162	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—AKR1C3—stomach cancer	5.72e-05	0.000159	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HTR1A—stomach cancer	5.66e-05	0.000157	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PPP2R1A—stomach cancer	5.61e-05	0.000156	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GSTP1—stomach cancer	5.51e-05	0.000153	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—ERCC2—stomach cancer	5.48e-05	0.000152	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ANXA1—stomach cancer	5.46e-05	0.000152	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PGLS—stomach cancer	5.46e-05	0.000152	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—BLVRB—stomach cancer	5.46e-05	0.000152	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—HMOX1—stomach cancer	5.43e-05	0.000151	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IRS2—stomach cancer	5.43e-05	0.000151	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—PPARG—stomach cancer	5.42e-05	0.000151	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ADRB1—stomach cancer	5.29e-05	0.000147	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CAV1—stomach cancer	5.26e-05	0.000146	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—APOA1—stomach cancer	5.25e-05	0.000146	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PPAP2A—stomach cancer	5.2e-05	0.000145	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—TYMS—stomach cancer	5.12e-05	0.000142	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GSTM1—stomach cancer	5.06e-05	0.000141	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—RPS6—stomach cancer	5.06e-05	0.000141	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PRKCB—stomach cancer	5.01e-05	0.000139	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IL6ST—stomach cancer	4.99e-05	0.000139	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—MYC—stomach cancer	4.94e-05	0.000138	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—SERPINE1—stomach cancer	4.88e-05	0.000136	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—APC—stomach cancer	4.79e-05	0.000133	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ERCC2—stomach cancer	4.76e-05	0.000132	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HBEGF—stomach cancer	4.65e-05	0.000129	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—NDUFA2—stomach cancer	4.64e-05	0.000129	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—FBP1—stomach cancer	4.64e-05	0.000129	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CKB—stomach cancer	4.64e-05	0.000129	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CA1—stomach cancer	4.64e-05	0.000129	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—MTHFR—stomach cancer	4.47e-05	0.000124	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IL6R—stomach cancer	4.45e-05	0.000124	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PLIN2—stomach cancer	4.36e-05	0.000121	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ADRB2—stomach cancer	4.29e-05	0.000119	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CA2—stomach cancer	4.24e-05	0.000118	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PPP2R1A—stomach cancer	4.2e-05	0.000117	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—PPARG—stomach cancer	4.17e-05	0.000116	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—MAPK3—stomach cancer	4.17e-05	0.000116	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—SERPINE1—stomach cancer	4.17e-05	0.000116	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—NT5E—stomach cancer	4.13e-05	0.000115	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PGAM1—stomach cancer	4.13e-05	0.000115	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CAV1—stomach cancer	4.12e-05	0.000115	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—APOA1—stomach cancer	4.11e-05	0.000114	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—MYC—stomach cancer	4.05e-05	0.000113	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—RHOA—stomach cancer	4.02e-05	0.000112	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NOS3—stomach cancer	3.98e-05	0.000111	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ALDH7A1—stomach cancer	3.94e-05	0.00011	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PLCE1—stomach cancer	3.94e-05	0.00011	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.94e-05	0.00011	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SMAD4—stomach cancer	3.9e-05	0.000109	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—UMPS—stomach cancer	3.78e-05	0.000105	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—SERPINE1—stomach cancer	3.76e-05	0.000105	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—ERBB2—stomach cancer	3.72e-05	0.000104	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—FYN—stomach cancer	3.7e-05	0.000103	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PPARG—stomach cancer	3.63e-05	0.000101	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CXCL8—stomach cancer	3.53e-05	9.82e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ECHS1—stomach cancer	3.52e-05	9.78e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PDHA1—stomach cancer	3.52e-05	9.78e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—FGFR2—stomach cancer	3.48e-05	9.67e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CDKN1B—stomach cancer	3.45e-05	9.59e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—TYMP—stomach cancer	3.31e-05	9.2e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—FADS1—stomach cancer	3.31e-05	9.2e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CCND1—stomach cancer	3.29e-05	9.15e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—JUN—stomach cancer	3.28e-05	9.13e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ALB—stomach cancer	3.26e-05	9.07e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MMP9—stomach cancer	3.19e-05	8.88e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IRS2—stomach cancer	3.18e-05	8.86e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CDKN1A—stomach cancer	3.18e-05	8.85e-05	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—MAPK3—stomach cancer	3.18e-05	8.84e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—NOS3—stomach cancer	3.12e-05	8.68e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MAPK8—stomach cancer	3.1e-05	8.64e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SREBF2—stomach cancer	3.1e-05	8.61e-05	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—MYC—stomach cancer	3.09e-05	8.6e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CAV1—stomach cancer	3.09e-05	8.59e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—APOA1—stomach cancer	3.08e-05	8.57e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—RORA—stomach cancer	3.06e-05	8.51e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PRKCB—stomach cancer	2.94e-05	8.18e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IL6ST—stomach cancer	2.93e-05	8.14e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ALDOB—stomach cancer	2.87e-05	7.97e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—VEGFA—stomach cancer	2.87e-05	7.97e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PTGS2—stomach cancer	2.85e-05	7.94e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—STAT3—stomach cancer	2.84e-05	7.89e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—APC—stomach cancer	2.81e-05	7.82e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MAPK3—stomach cancer	2.71e-05	7.54e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ALOX5—stomach cancer	2.66e-05	7.41e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MYC—stomach cancer	2.64e-05	7.34e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—DPYD—stomach cancer	2.62e-05	7.29e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IL6R—stomach cancer	2.61e-05	7.27e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MAPK1—stomach cancer	2.58e-05	7.18e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—EGFR—stomach cancer	2.58e-05	7.17e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—MAPK3—stomach cancer	2.45e-05	6.81e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SERPINE1—stomach cancer	2.45e-05	6.8e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—KRAS—stomach cancer	2.44e-05	6.78e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—MYC—stomach cancer	2.38e-05	6.62e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—RHOA—stomach cancer	2.36e-05	6.56e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NOS3—stomach cancer	2.33e-05	6.5e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GSTT1—stomach cancer	2.32e-05	6.45e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CYP2A6—stomach cancer	2.29e-05	6.37e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PIK3CA—stomach cancer	2.24e-05	6.23e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—AKR1C3—stomach cancer	2.23e-05	6.2e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ERBB2—stomach cancer	2.18e-05	6.08e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ENO1—stomach cancer	2.17e-05	6.04e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TP53—stomach cancer	2.17e-05	6.02e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CXCL8—stomach cancer	2.07e-05	5.76e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—HRAS—stomach cancer	2.07e-05	5.76e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CDKN1B—stomach cancer	2.02e-05	5.63e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IL6—stomach cancer	1.98e-05	5.51e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CCND1—stomach cancer	1.93e-05	5.37e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CD44—stomach cancer	1.93e-05	5.36e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—JUN—stomach cancer	1.92e-05	5.36e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MMP9—stomach cancer	1.87e-05	5.21e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CDKN1A—stomach cancer	1.87e-05	5.19e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MAPK8—stomach cancer	1.82e-05	5.07e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PIK3CA—stomach cancer	1.75e-05	4.88e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—VEGFA—stomach cancer	1.68e-05	4.68e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—STAT3—stomach cancer	1.67e-05	4.63e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PPP2R1A—stomach cancer	1.64e-05	4.56e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GSTP1—stomach cancer	1.61e-05	4.47e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MAPK3—stomach cancer	1.59e-05	4.43e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—HMOX1—stomach cancer	1.58e-05	4.41e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MYC—stomach cancer	1.55e-05	4.31e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MAPK1—stomach cancer	1.51e-05	4.21e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—EGFR—stomach cancer	1.51e-05	4.21e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—TYMS—stomach cancer	1.49e-05	4.16e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GSTM1—stomach cancer	1.48e-05	4.11e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—KRAS—stomach cancer	1.43e-05	3.98e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ERCC2—stomach cancer	1.39e-05	3.86e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PIK3CA—stomach cancer	1.31e-05	3.65e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—MTHFR—stomach cancer	1.3e-05	3.63e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TP53—stomach cancer	1.27e-05	3.54e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HRAS—stomach cancer	1.22e-05	3.38e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CAV1—stomach cancer	1.2e-05	3.35e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—APOA1—stomach cancer	1.2e-05	3.34e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IL6—stomach cancer	1.16e-05	3.24e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PPARG—stomach cancer	1.06e-05	2.94e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ALB—stomach cancer	9.51e-06	2.65e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—NOS3—stomach cancer	9.1e-06	2.53e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PTGS2—stomach cancer	8.32e-06	2.32e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PIK3CA—stomach cancer	5.12e-06	1.42e-05	CbGpPWpGaD
